Thursday, October 8, 2020
October 7, 2020
LabRoots and the Cancer Research and Oncology Planning Committee are pleased to announce the 8th Annual Cancer Research and Oncology Virtual Event! This two day event will take place on October 7th and 8th, 2020 and will focus on advancements in prevention, diagnosis and treatment of different cancer types.
Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Each year we see progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.
The tracks for last year's event included:
Tumor Drug Resistance and Tumor Evolution
Radiation Resistance
Novel Cancer Therapeutics and Cancer Prevention
Health Disparities in Cancer
Molecular Guidance Versus Standard of Care
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Cancer Research and Oncology Virtual Event. Submission is free. Submit your abstract here.
See Cancer Research & Oncology - October 7-8